从"肝主疏泄"探讨情志致癌:中医病机与现代生物学特征关联研究OA
Exploring Emotional Factors in Cancer via"Liver Controlling Dispersion":Linking Traditional Chinese Medicine Pathogenesis with Modern Biology
在中医学理论体系中,"肝主疏泄"是维系人体生理功能平衡的核心机制之一,其对情志的调控尤为关键.肝的疏泄功能失常、情志失调可导致气机升降出入失常,引发"肝郁气滞"的病理状态,日久则形成"气滞→痰凝→血瘀→毒结"的病理链,为癌症的发生发展提供条件.从现代医学角度出发,这一中医病理过程分别与情志刺激引发的神经内分泌紊乱、慢性炎症与氧化应激损伤、免疫逃逸、肿瘤微环境重塑等机制有一定联系.该文将中医理论与现代生物学机制相结合,探讨情志在恶性肿瘤发生中的作用及"肝郁"状态对肿瘤生物学行为的影响;因此在恶性肿瘤防治中,应重视疏肝理气、调畅情志,并将其贯穿恶性肿瘤治疗的始终.
In the theoretical system of traditional Chinese medicine(TCM),"liver governs the free flow of Qi"is one of the core mechanisms for maintaining the balance of human physiological functions,and its regulation of emotions is par-ticularly crucial.Dysfunction of the liver's function of free flow of Qi and emotional imbalance can lead to abnormal Qi circulation,resulting in the pathological state of"liver Qi stagnation."Over time,this forms a pathological chain of"Qi stagnation to phlegm accumulation to blood stasis to toxin accumulation,"providing conditions for the occurrence and de-velopment of cancer.From the perspective of modern medicine,this TCM pathological process is related to mechanisms such as neuro-endocrine disorders induced by emotional stimulation,chronic inflammation and oxidative stress damage,immune escape,and tumor micro-environment remodeling.This article combines TCM theory with modern biological mechanisms to explore the role of emotions in the occurrence of malignant tumors and the influence of"liver Qi stagna-tion"on tumor biological behavior.Therefore,in the prevention and treatment of malignant tumors,it is important to em-phasize soothing the liver and regulating Qi,and to integrate this throughout the entire treatment process.
毛佳华;蔡昕钰;郑雪儿;沈敏鹤;阮善明
浙江中医药大学附属第一医院,浙江省中医院 浙江 杭州 310006浙江中医药大学附属第一医院,浙江省中医院 浙江 杭州 310006浙江中医药大学附属第一医院,浙江省中医院 浙江 杭州 310006浙江中医药大学附属第一医院,浙江省中医院 浙江 杭州 310006浙江中医药大学附属第一医院,浙江省中医院 浙江 杭州 310006
医药卫生
肝主疏泄情志恶性肿瘤神经-内分泌-免疫疏肝解郁
Liver governs the free flow of QiEmotionsMalignant tumorNeuro-endocrine immuneShugan Jieyu
《中医药临床杂志》 2026 (5)
870-875,6
2025年度国家中医药综合改革示范区科技共建项目重点项目(GZY-KJS-ZJ-2025-039)
评论